Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| PTK2B | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 268.0 | Evidence |
|
||||
| PTK2B | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 268.0 | Evidence | |||||
| PTK2B | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 268.0 | Evidence |
|
||||
| PTK2B | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 268.0 | Evidence | |||||
| PTK2B | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 268.0 | Evidence |
|
||||
| PTK2B | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 200.0 | Evidence | |||||
| PTK2B | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 200.0 | Evidence | |||||
| PTK2B | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 156.0 | Evidence |
|
||||
| PTK2B | SYK | SYK: Tyrosine-protein kinase SYK | 139.0 | Evidence |
|
||||
| PTK2B | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 139.0 | Evidence | |||||
| PTK2B | CRKL | CRKL: Crk-like protein | 139.0 | Evidence | |||||
| PTK2B | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 125.0 | Evidence | |||||
| PTK2B | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 121.0 | Evidence |
|
||||
| PTK2B | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 119.0 | Evidence |
|
||||
| PTK2B | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 119.0 | Evidence | |||||
| PTK2B | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 119.0 | Evidence | |||||
| PTK2B | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 119.0 | Evidence | |||||
| PTK2B | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 119.0 | Evidence |
|
||||
| PTK2B | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 119.0 | Evidence | |||||
| PTK2B | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 119.0 | Evidence | |||||
| PTK2B | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 119.0 | Evidence | |||||
| PTK2B | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 119.0 | Evidence |
|
||||
| PTK2B | LNK | SH2B3, LNK: SH2B adapter protein 3 | 119.0 | Evidence | |||||
| PTK2B | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 117.0 | Evidence | |||||
| PTK2B | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 106.0 | Evidence | |||||
| PTK2B | LYN | LYN: Tyrosine-protein kinase Lyn | 106.0 | Evidence |
|
||||
| PTK2B | CSK | CSK: Tyrosine-protein kinase CSK | 106.0 | Evidence | |||||
| PTK2B | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 106.0 | Evidence | |||||
| PTK2B | APS | SH2B2, APS: SH2B adapter protein 2 | 106.0 | Evidence | |||||
| PTK2B | VAV1 | VAV1, VAV: Proto-oncogene vav | 106.0 | Evidence |
|
||||
| PTK2B | HCK | N/A | 106.0 | Evidence | |||||
| PTK2B | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 106.0 | Evidence |
|
||||
| PTK2B | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 106.0 | Evidence | |||||
| PTK2B | JAK1 | 106.0 | Evidence |
|
|||||
| PTK2B | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 106.0 | Evidence | |||||
| PTK2B | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 106.0 | Evidence | |||||
| PTK2B | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 106.0 | Evidence | |||||
| PTK2B | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 106.0 | Evidence |
|
||||
| PTK2B | STAT3 | 106.0 | Evidence |
|
|||||
| PTK2B | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 104.0 | Evidence | |||||
| PTK2B | CBLC | CBLC, CBL3, RNF57: Signal transduction protein CBL-C | 89.20 | Evidence | |||||
| PTK2B | GRB10 | N/A | 56.20 | Evidence | |||||
| PTK2B | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 32.90 | Evidence | |||||
| PTK2B | GRAP | GRAP: GRB2-related adapter protein | 32.90 | Evidence | |||||
| PTK2B | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 31.60 | Evidence | |||||
| PTK2B | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 22.30 | Evidence | |||||
| PTK2B | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 22.30 | Evidence | |||||
| PTK2B | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 22.30 | Evidence |
|
||||
| PTK2B | KIT | KIT: Mast/stem cell growth factor receptor precursor | 22.30 | Evidence | |||||
| PTK2B | SHB | SHB: SH2 domain-containing adapter protein B | 21.50 | Evidence | |||||
| PTK2B | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 21.50 | Evidence | |||||
| PTK2B | STAM2 | STAM2: Signal transducing adapter molecule 2 | 20.50 | Evidence | |||||
| PTK2B | CTTN | CTTN, EMS1: Src substrate cortactin | 15.00 | Evidence | |||||
| PTK2B | IRS2 | IRS2: Insulin receptor substrate 2 | 15.00 | Evidence | |||||
| PTK2B | IRS1 | IRS1: Insulin receptor substrate 1 | 15.00 | Evidence | |||||
| PTK2B | EFNB2 | EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor | 14.10 | Evidence | |||||
| PTK2B | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 13.50 | Evidence |
|
||||
| PTK2B | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 13.50 | Evidence |
|
||||
| PTK2B | INSR | INSR: Insulin receptor precursor | 13.50 | Evidence | |||||
| PTK2B | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 13.50 | Evidence | |||||
| PTK2B | CD2AP | CD2AP: CD2-associated protein | 13.40 | Evidence | |||||
| PTK2B | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 13.40 | Evidence | |||||
| PTK2B | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 13.40 | Evidence | |||||
| PTK2B | DOK1 | DOK1: Docking protein 1 | 13.40 | Evidence | |||||
| PTK2B | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 13.40 | Evidence | |||||